123 related articles for article (PubMed ID: 18599294)
1. Hepatitis C NS5B polymerase inhibitors: 4,4-Dialkyl-1-hydroxy-3-oxo-3,4-dihydronaphthalene-3-yl benzothiadiazine derivatives.
Hutchinson DK; Rosenberg T; Klein LL; Bosse TD; Larson DP; He W; Jiang WW; Kati WM; Kohlbrenner WE; Liu Y; Masse SV; Middleton T; Molla A; Montgomery DA; Beno DW; Stewart KD; Stoll VS; Kempf DJ
Bioorg Med Chem Lett; 2008 Jul; 18(14):3887-90. PubMed ID: 18599294
[TBL] [Abstract][Full Text] [Related]
2. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of unsymmetrical 1-hydroxy-4,4-dialkyl-3-oxo-3,4-dihydronaphthalene benzothiadiazine derivatives.
Krueger AC; Madigan DL; Green BE; Hutchinson DK; Jiang WW; Kati WM; Liu Y; Maring CJ; Masse SV; McDaniel KF; Middleton TR; Mo H; Molla A; Montgomery DA; Ng TI; Kempf DJ
Bioorg Med Chem Lett; 2007 Apr; 17(8):2289-92. PubMed ID: 17300933
[TBL] [Abstract][Full Text] [Related]
3. Structure-based design, synthesis, and biological evaluation of 1,1-dioxoisothiazole and benzo[b]thiophene-1,1-dioxide derivatives as novel inhibitors of hepatitis C virus NS5B polymerase.
Kim SH; Tran MT; Ruebsam F; Xiang AX; Ayida B; McGuire H; Ellis D; Blazel J; Tran CV; Murphy DE; Webber SE; Zhou Y; Shah AM; Tsan M; Showalter RE; Patel R; Gobbi A; LeBrun LA; Bartkowski DM; Nolan TG; Norris DA; Sergeeva MV; Kirkovsky L; Zhao Q; Han Q; Kissinger CR
Bioorg Med Chem Lett; 2008 Jul; 18(14):4181-5. PubMed ID: 18554907
[TBL] [Abstract][Full Text] [Related]
4. HCV NS5B polymerase inhibitors 3: Synthesis and in vitro activity of 3-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-4-hydroxy-2H-quinolizin-2-one derivatives.
Wang G; Zhang L; Wu X; Das D; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Buckman BO; Kossen K; Seiwert SD; Beigelman L
Bioorg Med Chem Lett; 2009 Aug; 19(15):4484-7. PubMed ID: 19497737
[TBL] [Abstract][Full Text] [Related]
5. HCV NS5B polymerase inhibitors 1: Synthesis and in vitro activity of 2-(1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl)-1-hydroxynaphthalene derivatives.
Wang G; He Y; Sun J; Das D; Hu M; Huang J; Ruhrmund D; Hooi L; Misialek S; Ravi Rajagopalan PT; Stoycheva A; Buckman BO; Kossen K; Seiwert SD; Beigelman L
Bioorg Med Chem Lett; 2009 Aug; 19(15):4476-9. PubMed ID: 19502055
[TBL] [Abstract][Full Text] [Related]
6. Substituted benzothiadizine inhibitors of Hepatitis C virus polymerase.
Shaw AN; Tedesco R; Bambal R; Chai D; Concha NO; Darcy MG; Dhanak D; Duffy KJ; Fitch DM; Gates A; Johnston VK; Keenan RM; Lin-Goerke J; Liu N; Sarisky RT; Wiggall KJ; Zimmerman MN
Bioorg Med Chem Lett; 2009 Aug; 19(15):4350-3. PubMed ID: 19515564
[TBL] [Abstract][Full Text] [Related]
7. HCV NS5B polymerase inhibitors 2: Synthesis and in vitro activity of (1,1-dioxo-2H-[1,2,4]benzothiadiazin-3-yl) azolo[1,5-a]pyridine and azolo[1,5-a]pyrimidine derivatives.
Wang G; Lei H; Wang X; Das D; Hong J; Mackinnon CH; Coulter TS; Montalbetti CA; Mears R; Gai X; Bailey SE; Ruhrmund D; Hooi L; Misialek S; Rajagopalan PT; Cheng RK; Barker JJ; Felicetti B; Schönfeld DL; Stoycheva A; Buckman BO; Kossen K; Seiwert SD; Beigelman L
Bioorg Med Chem Lett; 2009 Aug; 19(15):4480-3. PubMed ID: 19500983
[TBL] [Abstract][Full Text] [Related]
8. Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda6-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones: Part 4. Optimization of DMPK properties.
Sergeeva MV; Zhou Y; Bartkowski DM; Nolan TG; Norris DA; Okamoto E; Kirkovsky L; Kamran R; Lebrun LA; Tsan M; Patel R; Shah AM; Lardy M; Gobbi A; Li LS; Zhao J; Bertolini T; Stankovic N; Sun Z; Murphy DE; Webber SE; Dragovich PS
Bioorg Med Chem Lett; 2008 Jun; 18(11):3421-6. PubMed ID: 18442904
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological activity of heteroaryl 3-(1,1-dioxo-2H-(1,2,4)-benzothiadizin-3-yl)-4-hydroxy-2(1H)-quinolinone derivatives as hepatitis C virus NS5B polymerase inhibitors.
Tedesco R; Chai D; Darcy MG; Dhanak D; Fitch DM; Gates A; Johnston VK; Keenan RM; Lin-Goerke J; Sarisky RT; Shaw AN; Valko KL; Wiggall KJ; Zimmerman MN; Duffy KJ
Bioorg Med Chem Lett; 2009 Aug; 19(15):4354-8. PubMed ID: 19505821
[TBL] [Abstract][Full Text] [Related]
10. Activity of a potent hepatitis C virus polymerase inhibitor in the chimpanzee model.
Chen CM; He Y; Lu L; Lim HB; Tripathi RL; Middleton T; Hernandez LE; Beno DW; Long MA; Kati WM; Bosse TD; Larson DP; Wagner R; Lanford RE; Kohlbrenner WE; Kempf DJ; Pilot-Matias TJ; Molla A
Antimicrob Agents Chemother; 2007 Dec; 51(12):4290-6. PubMed ID: 17908950
[TBL] [Abstract][Full Text] [Related]
11. Inhibitors of HCV NS5B polymerase: synthesis and structure-activity relationships of N-1-benzyl and N-1-[3-methylbutyl]-4-hydroxy-1,8-naphthyridon-3-yl benzothiadiazine analogs containing substituents on the aromatic ring.
Rockway TW; Zhang R; Liu D; Betebenner DA; McDaniel KF; Pratt JK; Beno D; Montgomery D; Jiang WW; Masse S; Kati WM; Middleton T; Molla A; Maring CJ; Kempf DJ
Bioorg Med Chem Lett; 2006 Jul; 16(14):3833-8. PubMed ID: 16650984
[TBL] [Abstract][Full Text] [Related]
12. Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 3: Further optimization of the 2-, 6-, and 7'-substituents and initial pharmacokinetic assessments.
Li LS; Zhou Y; Murphy DE; Stankovic N; Zhao J; Dragovich PS; Bertolini T; Sun Z; Ayida B; Tran CV; Ruebsam F; Webber SE; Shah AM; Tsan M; Showalter RE; Patel R; Lebrun LA; Bartkowski DM; Nolan TG; Norris DA; Kamran R; Brooks J; Sergeeva MV; Kirkovsky L; Zhao Q; Kissinger CR
Bioorg Med Chem Lett; 2008 Jun; 18(11):3446-55. PubMed ID: 18457949
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and biological characterization of B-ring amino analogues of potent benzothiadiazine hepatitis C virus polymerase inhibitors.
Randolph JT; Flentge CA; Huang PP; Hutchinson DK; Klein LL; Lim HB; Mondal R; Reisch T; Montgomery DA; Jiang WW; Masse SV; Hernandez LE; Henry RF; Liu Y; Koev G; Kati WM; Stewart KD; Beno DW; Molla A; Kempf DJ
J Med Chem; 2009 May; 52(10):3174-83. PubMed ID: 19402666
[TBL] [Abstract][Full Text] [Related]
14. 1,5-Benzodiazepine inhibitors of HCV NS5B polymerase.
McGowan D; Nyanguile O; Cummings MD; Vendeville S; Vandyck K; Van den Broeck W; Boutton CW; De Bondt H; Quirynen L; Amssoms K; Bonfanti JF; Last S; Rombauts K; Tahri A; Hu L; Delouvroy F; Vermeiren K; Vandercruyssen G; Van der Helm L; Cleiren E; Mostmans W; Lory P; Pille G; Van Emelen K; Fanning G; Pauwels F; Lin TI; Simmen K; Raboisson P
Bioorg Med Chem Lett; 2009 May; 19(9):2492-6. PubMed ID: 19342234
[TBL] [Abstract][Full Text] [Related]
15. Novel HCV NS5B polymerase inhibitors derived from 4-(1',1'-dioxo-1',4'-dihydro-1'lambda(6)-benzo[1',2',4']thiadiazin-3'-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 5: Exploration of pyridazinones containing 6-amino-substituents.
Dragovich PS; Blazel JK; Ellis DA; Han Q; Kamran R; Kissinger CR; LeBrun LA; Li LS; Murphy DE; Noble M; Patel RA; Ruebsam F; Sergeeva MV; Shah AM; Showalter RE; Tran CV; Tsan M; Webber SE; Kirkovsky L; Zhou Y
Bioorg Med Chem Lett; 2008 Oct; 18(20):5635-9. PubMed ID: 18796353
[TBL] [Abstract][Full Text] [Related]
16. 2-hydroxy-1-oxo-1,2-dihydroisoquinoline-3-carboxylic acid with inbuilt β-N-hydroxy-γ-keto-acid pharmacophore as HCV NS5B polymerase inhibitors.
Deore RR; Chen GS; Chen CS; Chang PT; Chuang MH; Chern TR; Wang HC; Chern JW
Curr Med Chem; 2012; 19(4):613-24. PubMed ID: 22204334
[TBL] [Abstract][Full Text] [Related]
17. Discovery of tricyclic 5,6-dihydro-1H-pyridin-2-ones as novel, potent, and orally bioavailable inhibitors of HCV NS5B polymerase.
Ruebsam F; Murphy DE; Tran CV; Li LS; Zhao J; Dragovich PS; McGuire HM; Xiang AX; Sun Z; Ayida BK; Blazel JK; Kim SH; Zhou Y; Han Q; Kissinger CR; Webber SE; Showalter RE; Shah AM; Tsan M; Patel RA; Thompson PA; Lebrun LA; Hou HJ; Kamran R; Sergeeva MV; Bartkowski DM; Nolan TG; Norris DA; Khandurina J; Brooks J; Okamoto E; Kirkovsky L
Bioorg Med Chem Lett; 2009 Nov; 19(22):6404-12. PubMed ID: 19818610
[TBL] [Abstract][Full Text] [Related]
18. Phosphorous acid analogs of novel P2-P4 macrocycles as inhibitors of HCV-NS3 protease.
Pompei M; Francesco ME; Koch U; Liverton NJ; Summa V
Bioorg Med Chem Lett; 2009 May; 19(9):2574-8. PubMed ID: 19328685
[TBL] [Abstract][Full Text] [Related]
19. 3-heterocyclyl quinolone inhibitors of the HCV NS5B polymerase.
Kumar DV; Rai R; Brameld KA; Riggs J; Somoza JR; Rajagopalan R; Janc JW; Xia YM; Ton TL; Hu H; Lehoux I; Ho JD; Young WB; Hart B; Green MJ
Bioorg Med Chem Lett; 2012 Jan; 22(1):300-4. PubMed ID: 22119470
[TBL] [Abstract][Full Text] [Related]
20. 4-(1,1-Dioxo-1,4-dihydro-1lambda6-benzo[1,4]thiazin-3-yl)-5-hydroxy-2H-pyridazin-3-ones as potent inhibitors of HCV NS5B polymerase.
Ellis DA; Blazel JK; Webber SE; Tran CV; Dragovich PS; Sun Z; Ruebsam F; McGuire HM; Xiang AX; Zhao J; Li LS; Zhou Y; Han Q; Kissinger CR; Showalter RE; Lardy M; Shah AM; Tsan M; Patel R; LeBrun LA; Kamran R; Bartkowski DM; Nolan TG; Norris DA; Sergeeva MV; Kirkovsky L
Bioorg Med Chem Lett; 2008 Aug; 18(16):4628-32. PubMed ID: 18662878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
